Redhill Biopharma Ltd. (RDHL): Price and Financial Metrics
RDHL Price/Volume Stats
| Current price | $6.50 | 52-week high | $40.50 |
| Prev. close | $6.47 | 52-week low | $6.00 |
| Day low | $6.30 | Volume | 12,600 |
| Day high | $6.68 | Avg. volume | 104,649 |
| 50-day MA | $7.70 | Dividend yield | N/A |
| 200-day MA | $9.87 | Market Cap | 8.33M |
RDHL Stock Price Chart Interactive Chart >
Redhill Biopharma Ltd. (RDHL) Company Bio
RedHill Biopharma Ltd. focuses on the development and acquisition of late clinical-stage, proprietary, and orally-administered drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers in Israel. The company was founded in 2009 and is based in Tel Aviv, Israel.
RDHL Price Returns
| 1-mo | -4.13% |
| 3-mo | -34.48% |
| 6-mo | -31.74% |
| 1-year | -82.31% |
| 3-year | -99.75% |
| 5-year | -99.89% |
| YTD | -82.19% |
| 2023 | -73.98% |
| 2022 | -94.56% |
| 2021 | -68.07% |
| 2020 | 33.11% |
| 2019 | 9.37% |
Continue Researching RDHL
Want to see what other sources are saying about RedHill Biopharma Ltd's financials and stock price? Try the links below:RedHill Biopharma Ltd (RDHL) Stock Price | Nasdaq
RedHill Biopharma Ltd (RDHL) Stock Quote, History and News - Yahoo Finance
RedHill Biopharma Ltd (RDHL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...